Citius Pharmaceuticals Inc vs Vistra Corp — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Vistra Corp trades at $146.15 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 2430.8× Citius Pharmaceuticals Inc's market cap, and Vistra Corp pays a 0.63% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | VST | |
|---|---|---|
Market Cap | $20.01M | $48.64B |
Sector | Health | Technology |
52-Week High | $1.82 | $217.92 |
52-Week Low | $0.48 | $134.71 |
Enterprise Value | $16.23M | $70.58B |
Dividend Yield | — | 0.63% |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →